Review
World J Hematol
2(3):62-70.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.62
Abstract (2322)
|
Core Tip (1653)
|
Full Article (HTML) (47830)
|
Figures (1-9) (922)
|
Full Article (PDF)-576K (2379)
|
Peer-Review Report-178K (434)
|
Answering Reviewers-107K (413)
|
Received: 04/01/2013
|
Revised: 05/14/2013
|
Accepted: 06/10/2013
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (60002)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms
World J Hematol
2(3):71-88.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.71
Abstract (1757)
|
Core Tip (1472)
|
Full Article (HTML) (9324)
|
Figures (1-10) (451)
|
Tables (1-6) (357)
|
Full Article (PDF)-3685K (916)
|
Peer-Review Report-98K (418)
|
Answering Reviewers-50K (334)
|
Received: 01/11/2013
|
Accepted: 06/18/2013
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (18089)
|
Similar Articles (5)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hematol
2(3):89-98.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.89
Abstract (1749)
|
Core Tip (1430)
|
Full Article (HTML) (7799)
|
Figures (1-6) (439)
|
Tables (1-2) (244)
|
Full Article (PDF)-1438K (727)
|
Peer-Review Report-192K (242)
|
Answering Reviewers-63K (260)
|
Received: 03/11/2013
|
Revised: 05/10/2013
|
Accepted: 06/06/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (16054)
|
Similar Articles (33)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open